Weldon Ryan
Insider CIK 1564233 · VRX EVP, Company Group Chairman
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| VRX Valeant Pharmaceuticals In | M Exercise deriv | 2014-04-28 | 2014-04-30 | 11,000 | — | $0 | 11,000 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise | 2014-04-28 | 2014-04-30 | 11,000 | — | $0 | 109,116 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2014-04-28 | 2014-04-30 | 5,707 | $122.05 | $696.5K | 103,409 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise deriv | 2014-02-11 | 2014-02-12 | 11,000 | — | $0 | 11,000 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2014-02-11 | 2014-02-12 | 5,707 | — | $0 | 98,116 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise | 2014-02-11 | 2014-02-12 | 11,000 | — | $0 | 103,823 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise deriv | 2014-01-24 | 2014-01-28 | 19,000 | — | $0 | 19,000 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise | 2014-01-24 | 2014-01-28 | 19,000 | — | $0 | 101,539 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2014-01-24 | 2014-01-28 | 8,716 | — | $0 | 92,823 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise deriv | 2013-10-24 | 2013-10-28 | 15,521 | — | $0 | 0 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise | 2013-10-24 | 2013-10-28 | 15,521 | — | $0 | 90,590 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2013-10-24 | 2013-10-28 | 8,051 | — | $0 | 82,539 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise deriv | 2013-09-03 | 2013-09-03 | 19,000 | — | $0 | 19,000 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise | 2013-09-03 | 2013-09-03 | 19,000 | — | $0 | 84,928 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2013-09-03 | 2013-09-03 | 9,859 | — | $0 | 75,069 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise deriv | 2013-07-26 | 2013-07-30 | 5,173 | — | $0 | 15,521 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise | 2013-07-26 | 2013-07-30 | 5,173 | — | $0 | 68,611 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2013-07-26 | 2013-07-30 | 2,683 | — | $0 | 65,928 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2013-07-25 | 2013-07-29 | 102 | — | $0 | 63,438 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise deriv | 2013-05-31 | 2013-06-04 | 20,694 | — | $0 | 20,694 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2013-05-31 | 2013-06-04 | 9,863 | — | $0 | 63,540 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise | 2013-05-31 | 2013-06-04 | 20,694 | — | $0 | 73,403 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award deriv | 2013-03-05 | 2013-03-06 | 13,700 | — | $0 | 13,700 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award deriv | 2013-01-28 | 2013-03-06 | 11,000 | — | $0 | 11,000 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award deriv | 2012-12-11 | 2012-12-13 | 19,000 | — | $0 | 19,000 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award deriv | 2012-12-11 | 2012-12-13 | 43,000 | $58.16 | $2.50M | 43,000 | SEC↗ |